Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation

被引:438
作者
Mansell, A
Smith, R
Doyle, SL
Gray, P
Fenner, JE
Crack, PJ
Nicholson, SE
Hilton, DJ
O'Neill, LAJ
Hertzog, PJ [1 ]
机构
[1] Monash Univ, Monash Inst Med Res, Ctr Funct Genom & Human Dis, Melbourne, Vic, Australia
[2] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland
[3] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia
基金
英国医学研究理事会; 爱尔兰科学基金会;
关键词
D O I
10.1038/ni1299
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptor (TLR) signals that initiate innate immune responses to pathogens must be tightly regulated to prevent excessive inflammatory damage to the host. The adaptor protein Mal is specifically involved in signaling via TLR2 and TLR4. We demonstrate here that after TLR2 and TLR4 stimulation Mal becomes phosphorylated by Bruton's tyrosine kinase (Btk) and then interacts with SOCS-1, which results in Mal polyubiquitination and subsequent degradation. Removal of SOCS-1 regulation potentiates Mal-dependent p65 phosphorylation and transactivation of NF-kappa B, leading to amplified inflammatory responses. These data identify a target of SOCS-1 that regulates TLR signaling via a mechanism distinct from an autocrine cytokine response. The transient activation of Mal and subsequent SOCS-1-mediated degradation is a rapid and selective means of limiting primary innate immune response.
引用
收藏
页码:148 / 155
页数:8
相关论文
共 42 条
  • [1] Toll-like receptor signalling
    Akira, S
    Takeda, K
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) : 499 - 511
  • [2] The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immuneresponse
    Alexander, WS
    Hilton, DJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 : 503 - 529
  • [3] SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
    Alexander, WS
    Starr, R
    Fenner, JE
    Scott, GL
    Handman, E
    Sprigg, NS
    Corbin, JE
    Cornish, AL
    Darwiche, R
    Owczarek, CM
    Kay, TWH
    Nicola, NA
    Hertzog, PJ
    Metcalf, D
    Hilton, DJ
    [J]. CELL, 1999, 98 (05) : 597 - 608
  • [4] Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells
    Baetz, A
    Frey, M
    Heeg, K
    Dalpke, AH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) : 54708 - 54715
  • [5] Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
    Chuang, TH
    Ulevitch, RJ
    [J]. NATURE IMMUNOLOGY, 2004, 5 (05) : 495 - 502
  • [6] Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
    Divanovic, S
    Trompette, A
    Atabani, SF
    Madan, R
    Golenbock, DT
    Visintin, A
    Finberg, RW
    Tarakhovsky, A
    Vogel, SN
    Belkaid, Y
    Kurt-Jones, EA
    Karp, CL
    [J]. NATURE IMMUNOLOGY, 2005, 6 (06) : 571 - 578
  • [7] Bruton's tyrosine kinase is involved in p65-mediated transactivation and phosphorylation of p65 on serine 536 during NFκB activation by lipopolysaccharide
    Doyle, SL
    Jefferies, CA
    O'Neill, LA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) : 23496 - 23501
  • [8] Adaptor usage and Toll-like receptor signaling specificity
    Dunne, A
    O'Neill, LAJ
    [J]. FEBS LETTERS, 2005, 579 (15) : 3330 - 3335
  • [9] A new protein containing an SH2 domain that inhibits JAK kinases
    Endo, TA
    Masuhara, M
    Yokouchi, M
    Suzuki, R
    Sakamoto, H
    Mitsui, K
    Matsumoto, A
    Tanimura, S
    Ohtsubo, M
    Misawa, H
    Miyazaki, T
    Leonor, N
    Taniguchi, T
    Fujita, T
    Kanakura, Y
    Komiya, S
    Yoshimura, A
    [J]. NATURE, 1997, 387 (6636) : 921 - 924
  • [10] Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity
    Fenner, JE
    Starr, R
    Cornish, AL
    Zhang, JG
    Metcalf, D
    Schreiber, RD
    Sheehan, K
    Hilton, DJ
    Alexander, WS
    Hertzog, PJ
    [J]. NATURE IMMUNOLOGY, 2006, 7 (01) : 33 - 39